Advertisement

Histamine in atrial fibrillation (AF) — Is there any connection? Results from an unselected population

Published:January 31, 2014DOI:https://doi.org/10.1016/j.ijcard.2013.12.185
      Atrial fibrillation (AF) is the most frequent heart rhythm disorder in the western world. Its occurrence may be associated with ischemic heart disease, structural cardiac alterations, mitral or tricuspid valve disease, arteriosclerosis, or hypertension [
      • Camm A.J.
      • Kirchhof P.
      • Lip G.Y.
      • et al.
      Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
      ]. However, only a minority of AF episodes may be fully explained by predisposing factors or cardiac diseases [
      • Schnabel R.B.
      • Wilde S.
      • Wild P.S.
      • Munzel T.
      • Blankenberg S.
      Atrial fibrillation: its prevalence and risk factor profile in the German general population.
      ].

      Abbreviations:

      AF (atrial fibrillation), BSA (body surface area), CAD (coronary artery disease), EF (ejection fraction), LA (left atrium)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Camm A.J.
        • Kirchhof P.
        • Lip G.Y.
        • et al.
        Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
        Eur Heart J. 2010; 19: 2369-429
        • Schnabel R.B.
        • Wilde S.
        • Wild P.S.
        • Munzel T.
        • Blankenberg S.
        Atrial fibrillation: its prevalence and risk factor profile in the German general population.
        Dtsch Arztebl Int. 2012; 109: 293-299
        • Bach J.F.
        The effect of infections on susceptibility to autoimmune and allergic diseases.
        N Engl J Med. 2002; 347: 911-920
        • Wollemann M.
        • Papp J.G.
        Blockade by cimetidine of the effects of histamine on adenylate cyclase activity, spontaneous rate and contractility in the developing praenatal heart.
        Agents Actions. 1979; 9: 29-30
        • McNeill J.H.
        • Verma S.C.
        Histamine receptors in rabbit heart.
        Proc West Pharmacol. 1978; 58: 1023-1030
        • Flynn S.B.
        • Gristwood R.W.
        • Owen D.A.
        Differentiation of the roles of histamine H1- and H2-receptors in the mediation of the effects of histamine in the isolated working heart of the guinea-pig.
        Br J Pharmacol. 1979; 65: 127-137
        • Wolff A.A.
        • Levi R.
        Histamine and cardiac arrhythmias.
        Circ Res. 1986; 58: 1-16
        • Ledda F.
        • Mannaioni P.F.
        • Giotti A.
        Interazioni fra beta-bloccanti, noradrenalina ed istamina sulla fibra di Purkinje del cuore di pecora.
        Boll Soc Ital Biol Sper. 1967; 43: 1384-1386
        • Rohr S.M.
        • Rich M.W.
        • Silver K.H.
        Shortness of breath, syncope, and cardiac arrest caused by systemic mastocytosis.
        Ann Emerg Med. 2005; 45: 592-594
        • Patel S.C.
        • Detjen P.F.
        Atrial fibrillation associated with anaphylaxis during venom and pollen immunotherapy.
        Ann Allergy Asthma Immunol. 2002; 89: 209-211
        • Raithel M.
        • Nägel A.
        • Zopf Y.
        • et al.
        Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active inflammatory bowel disease (IBD).
        Inflamm Res. 2010; 59: S257-S258
        • IBL Hamburg
        TNF-α ELISA, instruction for use.
        IBL Gesellschaft für Immunchemie und Immunbiologie MBH. 2006: 1-33
        • Petrovay F.
        • Heltai K.
        • Kis Z.
        • et al.
        Chronic infections and histamine, CRP and IL-6 levels after percutaneous transluminal coronary angioplasty.
        Inflamm Res. 2007; 56: 362-367
        • Corazza G.R.
        • Falasca A.
        • Strocchi A.
        • Rossi C.A.
        • Gasbarrini G.
        Decreased plasma postheparin diamine oxidase levels in celiac disease.
        Dig Dis Sci. 1988; 33: 956-961
        • Harkay J.
        Cardiac manifestations due to hypersensitivity.
        Ann Allergy. 1970; 28: 242-251
        • Pearce F.L.
        Biological effects of histamine.
        Agents Actions. 1991; 33: 4-7
        • Levi R.
        • Chenouda A.A.
        • Trzeciakowski J.P.
        • et al.
        Dysrhythmias caused by histamine release in guinea pig and human hearts.
        Klin Wochenschrift. 1982; 60: 965-971
        • Jarisch R.
        • Götz M.
        • Raithel M.
        Histamin – Intoleranz. Histamin und Seekrankheit. 1. und 2.
        Auflage Stuttgart, New York, Thieme Verlag2004
        • Homann J.
        • Kolck U.W.
        • Ehnes A.
        • Frieling Th.
        • Raithel M.
        • Molderings G.J.
        Die systemische Mastozytose – Standortbestimmung einer internistischen Erkrankung [Systemic mastocytosis – definition of an internal disease].
        Med Klin. 2010/8; 105: 544-555
        • Liang Y.
        • Mente A.
        • Yusuf S.
        • et al.
        Alcohol consumption and the risk of incident atrial fibrillation among people with cardiovascular disease.
        CMAJ. 2012; 184: E857-E866
        • Maintz L.
        • Novak N.
        Histamine and histamine intolerance.
        Am J Clin Nutr. 2007; 85: 1185-1196